EVMN Evommune, Inc.

NEUTRAL Impact: 3/10 Insider Cluster (2 insiders)
Horizon days Filed Jun 2, 2026 Processed 11d 9h ago
Insider cluster: 2 insiders, $740K total
Latest settled — T+1d ⚠ clustered
EVMN ▼ -0.45% at T+1d
NEUTRAL call ✗ call lost -0.45% · α vs SPY +0.27% · entry $19.82 → $19.73
Next anchor: T+5d due 5d ago
Currently $19.83 · +0.05% from $19.82 entry
Entry anchored
Jun 1, 2026
via day open
T+1d
-0.45%
call -0.45% · α +0.27%
$19.73
settled 11d ago
T+5d
call — · α —
due 5d ago
T+20d
call — · α —
in 17d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

CFO and Chief Business & Legal Officer sold a combined $740K in open-market sales on May 28, 2026, following derivative exercises at nominal prices. The sales are modest relative to the $837M market cap (~0.09%), and the pattern (same-day exercise-and-sell, similar sizes) suggests tax- or liquidity-driven selling rather than informed bearishness. The cluster is amplified by cross-filing actuarial signals, but the absolute dollar amount is below the materiality threshold.

Key Financial Metrics

Direction
selling
Total Value
$740.0K
Insiders
2

Actionable Insight

The cluster is routine in size and pattern — no bearish signal. Monitor next 10-Q for any operational deterioration that might have prompted the sales, but the dollar amount does not warrant action.

Key Facts

  • CFO Carver sold 18,175 shares at $22.84 for $415K after exercising 15,000 options at $2.99/share.
  • Chief Business & Legal Officer Moss sold 14,223 shares at $22.83 for $325K after exercising options at $0 and $1.71.
  • Total open-market sales: $740K, representing ~0.09% of the $837M market cap.
  • Both sales occurred on the same day (May 28, 2026), consistent with a post-vesting blackout-window opening or 10b5-1 plan.
  • No open-market purchases were made by any insider in the cluster.

Financial Impact

Sales of $740K are trivial relative to $837M market cap (0.09%). No material financial impact.

insider ownershipdilution

Risk Factors

  • Insiders may have additional unexercised options that could lead to further sales in future windows.
  • Historical performance on EVMN reports shows poor predictive accuracy (0% win rate at T+20), suggesting limited edge from this filing type.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (16 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-EVMN-1780358434141
9 reports for EVMN
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+5▲ +14.25%May 28, 2026
Filters
Rows
Reports for EVMN — sortable, filterable
Type Now
Jun 4, 2026
9d ago
Insider Cluster
BEARISH ★ 5/10
$20.69 $19.92▲ +3.72%▲ +1.12%$19.83 (+4.16%)
Jun 2, 2026
10d ago
144
NEUTRAL ★ 3/10
$19.73 $20.69▲ +4.87%▲ +4.47%$19.83 (+0.51%)
Jun 2, 2026
11d ago
Insider Cluster
NEUTRAL ★ 3/10
$19.82 $19.73▼ −0.45%▲ +0.27%$19.83 (+0.05%)
May 28, 2026
15d ago
144
BEARISH ★ 5/10
$23.23 $22.17▲ +4.56%▲ +4.82%$19.83 (+14.64%)
Apr 27, 2026
6w ago
EFFECT
NEUTRAL ★ 4/10
$25.00 $25.58▲ +2.32%▲ +2.81%$19.83 (−20.68%)
Apr 21, 2026
7w ago
DEFA14A
NEUTRAL ★ 3/10
$27.12 $25.84▼ −4.72%▼ −4.33%$19.83 (−26.88%)
Apr 17, 2026
8w ago
S-1
NEUTRAL ★ 4/10
$27.97 $28.07▲ +0.36%▲ +1.01%$19.83 (−29.10%)
Apr 13, 2026
8w ago
8-K
NEUTRAL ★ 3/10
$26.63 $26.94▲ +1.16%▲ +0.39%$19.83 (−25.54%)
Mar 5, 2026
14w ago
8-K
BULLISH ★ 8/10
$26.50 $24.61▼ −7.13%▼ −7.98%$19.83 (−25.17%)
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (52h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access